Notice of Closed Meeting, 78367 [2023-25120]
Download as PDF
<![CDATA[
78367
Federal Register / Vol. 88, No. 219 / Wednesday, November 15, 2023 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
57.132 New Form—Patient Safety Component FHIR Measures-HOB, HT–CDI Modules-IT
Yearly Maintenance .................................................................................................................
57.132 New Form—Patient Safety Component FHIR Measures-HOB, HT–CDI Modules-Infection Preventionist ......................................................................................................................
57.133 New Form—Patient Safety Component FHIR Measures-VTE Module-IT Initial Set up
57.133 New Form—Patient Safety Component FHIR Measures-VTE Module-IT Yearly Maintenance .....................................................................................................................................
57.133 New Form—Patient Safety Component FHIR Measures-VTE Module- Infection
Preventionist .............................................................................................................................
57.600 New Form—Neonatal Component FHIR Measure-Late Onset Sepsis Meningitis
(LOSMEN) Module-IT Initial Set up .........................................................................................
57.600 New Form—Neonatal Component FHIR Measure-Late Onset Sepsis Meningitis
(LOSMEN) Module-IT Yearly Maintenance .............................................................................
57.600 New Form—Neonatal Component FHIR Measure-Late Onset Sepsis Meningitis
(LOSMEN) Module-Infection Preventionist ..............................................................................
57.600 New Form—Neonatal Component Late Onset Sepsis Meningitis (LOSMEN) Module
CDA Data Collection-Infection Preventionist ...........................................................................
57.700 New Form—Medication Safety Component FHIR Measure-Glycemic Control Module
Hypoglycemia-IT Initial Set up .................................................................................................
57.700 New Form—Medication Safety Component FHIR Measure-Glycemic Control Module
Hypoglycemia-IT Yearly Maintenance .....................................................................................
57.700 New Form—Medication Safety Component FHIR Measure-Glycemic Control Module
Hypoglycemia-Infection Preventionist ......................................................................................
57.701 New Form—Glycemic Control Module-HYPO Annual Survey ........................................
57.144 New Form—Long Term Care Respiratory Tract Infections (RTI) Module ......................
57.145 New Form—Long Term Care Antimicrobial Use (LTC–AU) Module CDA .....................
New Form—Billing Code Data: 837I Upload ...............................................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–25156 Filed 11–14–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
ddrumheller on DSK120RN23PROD with NOTICES1
Notice of Closed Meeting
In accordance with 5 U.S.C. 1009(d),
the Centers for Disease Control and
Prevention (CDC) announces the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463.
Name of Committee: Safety and
Occupational Health Study Section
(SOHSS), National Institute for
Occupational Safety and Health
(NIOSH).
Dates: February 6–7, 2024.
Times: 11 a.m.–5 p.m., EST.
Place: Teleconference.
VerDate Sep<11>2014
17:49 Nov 14, 2023
Jkt 262001
Agenda: The meeting will convene to
address matters related to the conduct of
Study Section business and for the
Study Section to consider safety and
occupational health-related grant
applications.
For Further Information Contact:
Michael Goldcamp, Ph.D., Scientific
Review Officer, Office of Extramural
Programs, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1095 Willowdale Road, Morgantown,
West Virginia 26506. Telephone: (304)
285–5951; Email: MGoldcamp@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023–25120 Filed 11–14–23; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00085
Number of
responses per
respondent
Avg. burden
per response
(min./hour 60)
5500
1
1200/60
5500
5500
6
1
6/60
1620/60
5500
1
1200/60
5500
6
6/60
5500
1
1620/60
5500
1
1200/60
5500
6
6/60
5500
12
2/60
5500
1
1620/60
5500
1
1200/60
5500
10
16,500
16,500
5500
6
1
24
12
4
6/60
120/60
25/60
5/60
5/60
Number of
respondents
Form number and name
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10662]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
SUMMARY:
E:\FR\FM\15NON1.SGM
15NON1
]]>Agencies
[Federal Register Volume 88, Number 219 (Wednesday, November 15, 2023)]
[Notices]
[Page 78367]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-25120]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
In accordance with 5 U.S.C. 1009(d), the Centers for Disease
Control and Prevention (CDC) announces the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended, and the Determination of the Director, Office of
Strategic Business Initiatives, Office of the Chief Operating Officer,
CDC, pursuant to Public Law 92-463.
Name of Committee: Safety and Occupational Health Study Section
(SOHSS), National Institute for Occupational Safety and Health (NIOSH).
Dates: February 6-7, 2024.
Times: 11 a.m.-5 p.m., EST.
Place: Teleconference.
Agenda: The meeting will convene to address matters related to the
conduct of Study Section business and for the Study Section to consider
safety and occupational health-related grant applications.
For Further Information Contact: Michael Goldcamp, Ph.D.,
Scientific Review Officer, Office of Extramural Programs, National
Institute for Occupational Safety and Health, Centers for Disease
Control and Prevention, 1095 Willowdale Road, Morgantown, West Virginia
26506. Telephone: (304) 285-5951; Email: [email protected].
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-25120 Filed 11-14-23; 8:45 am]
BILLING CODE 4163-18-P
